AeroLeads people directory · profile
Thomas Spangenberg Email & Phone Number
Head of Global Health Open Innovation and Drug Discovery
at
Merck
1 work email found
@yahoo.fr
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Head of Global Health Open Innovation and Drug Discovery
Location
Geneva, Geneva, Switzerland
Who is Thomas Spangenberg? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Thomas Spangenberg is listed as Head of Global Health Open Innovation and Drug Discovery at Merck, based in Geneva, Geneva, Switzerland. AeroLeads shows a work email signal at yahoo.fr and a matched LinkedIn profile for Thomas Spangenberg.
Thomas Spangenberg previously worked as Research Scientist - Discovery at Medicines For Malaria Venture and Post doctoral scientist at Merck Serono. Thomas Spangenberg holds Post Doctorate from Harvard University.
Company email context
Email format at Merck
This section adds company-level context without repeating Thomas Spangenberg's masked contact details.
{first_initial}{last}@yahoo.fr
76% confidence
AeroLeads found 1 current-domain work email signal for Thomas Spangenberg. Compare company email patterns before reaching out.
Profile bio
About Thomas Spangenberg
Thomas Spangenberg is a Head of Global Health Open Innovation and Drug Discovery at Merck. He possess expertise in chemistry, organic chemistry, lifesciences, drug discovery, lc ms and 14 more skills. He is proficient in Dutch.
Listed skills include Chemistry, Organic Chemistry, Lifesciences, Drug Discovery, and 15 others.
Current workplace
Thomas Spangenberg's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 25 years
Thomas Spangenberg work experience
A career timeline built from the work history available for this profile.
Head Of Global Health Open Innovation And Drug Discovery
Current
Feb 2015 - Present
Research Scientist - Discovery
Focusing on the early stages of the pipeline from compound screening to candidate selection. Specifically working as a lead chemist.Project leader for the Malaria Box and Pathogen Box initiatives, which are open source projects designed to catalyse drug discovery research in neglected diseases.
Oct 2011 - Jan 2015
Post Doctoral Scientist
Ligand-based lead optimisation of a new strain resistant anti-malarial drug candidate: Fine-tuned right balance between in vitro potency and PK/PD profile. Circumvented safety liabilities (hERG, CYP2D6 inh.) to fulfill the Target Compound Profile.Responsible for overseeing the hit discovery process with external collaborators against S. mansoni.
Aug 2010 - Jul 2011
Temporary Adviser
Established a new chemically-based diagnostic test for Buruli ulcer, a skin disease caused by Mycobacterium ulcerans.Trained laboratory staff to use this method.
May 2010 - May 2010
Post Doctoral Research Scientist
Total synthesis and structure assignment of the minor metabolite arising from Mycobacterium liflandii. Therapeutic area of neglected tropical diseases: Researched and developed a point-of-care diagnosis for Buruli ulcer via a luminescent detection method for the mycolactones.
Jan 2009 - Jan 2010
Comité D'Organisation
Seco45
2008 - 2008
Teaching Associate
Practical work and tutorial for first-year and second-year students: Organic Chemistry and Methodology of Chemistry.
2005 - 2008
~3 yrs
Exchange Student
Lacdr
Synthesized 2,6,8-trisubstituted 1-deazapurines as potential adenosine A1 receptor inverse agonists.Refined the pharmacophore for in vitro selectivity profile of adenosine-GPCRs (A1/A2A/A3). Therapeutic area: Cognition & sleeping disorders.
2004 - 2004
Technician
Implemented a normalized analytical method for the oxygen induction time on high density polyethylene by DSC.
Jul 2003 - Aug 2003
Research Associate
Designed and synthesized high and low melting acid developers for the chromonyx project.
2002 - 2002
Research Associate
Synthesized and studied the SAR of novel chiral analgesic alkaloids acting as μ-agonists in the therapeutic area of neuropathic pain. Refined the selectivity profile of opioid-GPCRs (μ/δ/κ) and improved their metabolic stability.
2001 - 2002
~1 yr
5 education records
Thomas Spangenberg education
Post Doctorate
Harvard University
Phd, Chemistry
The University Of Freiburg
Bsc, Msc, Phd, Organic Chemistry
Université Louis Pasteur (Strasbourg I)
Education record
European Doctoral College Of Strasbourg
Msc, Organic Chemistry
Leiden University
FAQ
Frequently asked questions about Thomas Spangenberg
Quick answers generated from the profile data available on this page.
What company does Thomas Spangenberg work for?
Thomas Spangenberg works for Merck.
What is Thomas Spangenberg's role at Merck?
Thomas Spangenberg is listed as Head of Global Health Open Innovation and Drug Discovery at Merck.
What is Thomas Spangenberg's email address?
AeroLeads has found 1 work email signal at @yahoo.fr for Thomas Spangenberg at Merck.
Where is Thomas Spangenberg based?
Thomas Spangenberg is based in Geneva, Geneva, Switzerland while working with Merck.
What companies has Thomas Spangenberg worked for?
Thomas Spangenberg has worked for Merck, Medicines For Malaria Venture, Merck Serono, World Health Organization, and Harvard University.
How can I contact Thomas Spangenberg?
You can use AeroLeads to view verified contact signals for Thomas Spangenberg at Merck, including work email, phone, and LinkedIn data when available.
What schools did Thomas Spangenberg attend?
Thomas Spangenberg holds Post Doctorate from Harvard University.
What skills is Thomas Spangenberg known for?
Thomas Spangenberg is listed with skills including Chemistry, Organic Chemistry, Lifesciences, Drug Discovery, Lc Ms, Organic Synthesis, Medicinal Chemistry, and Hplc.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial